A PILOT STUDY OF BRENTUXIMAB VEDOTIN AND AVD CHEMOTHERAPY FOLLOWED BY 20 GY INVOLVED-SITE RADIOTHERAPY IN EARLY STAGE, UNFAVORABLE RISK HODGKIN LYMPHOMA

Autor:	Elizabeth Budde, Ranjana H. Advani, Richard T. Hoppe, Heiko Schöder, Anita Kumar, Amanda I. Courtien, Paul M. Barr, Joachim Yahalom, Craig H. Moskowitz, Shoshana T. Miller, Gianna N. McArthur, Carla Casulo, Ariela Noy, M. Matasar, Paul A. Hamlin, Pamela Drullinsky, A.J. Moskowitz, Andrew D. Zelenetz, David J. Straus, S.V. Dandapani, Jonathan W. Friedberg, Joanna C. Yang, Connie Lee Batlevi, Louis S. Constine, Robert T. Chen, Anas Younes
Rok vydání:	2017
Předmět:	Oncology Cancer Research medicine.medical_specialty Chemotherapy business.industry medicine.medical_treatment Hematology General Medicine Radiation therapy Internal medicine medicine Hodgkin lymphoma Stage (cooking) Brentuximab vedotin business medicine.drug
Zdroj:	Hematological Oncology. 35:171-172
ISSN:	0278-0232
DOI:	10.1002/hon.2438_30
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::c2c1fdd80e816cb2ac84bc32d139c924 https://doi.org/10.1002/hon.2438_30 Zobrazit plný text záznamu Plný text